Old Web
English
Sign In
Acemap
>
authorDetail
>
Emma C. Scott
Emma C. Scott
Food and Drug Administration
Immunology
Internal medicine
Adverse effect
Isocitrate dehydrogenase
Myeloid leukemia
2
Papers
21
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Differentiation syndrome with ivosidenib and enasidenib treatment in patients with relapsed or refractory IDH-mutated AML: a U.S. Food and Drug Administration systematic analysis.
2020
Clinical Cancer Research
Kelly J. Norsworthy
Flora Mulkey
Emma C. Scott
Ashley F. Ward
Donna Przepiorka
Rosane Charlab
Sarah E. Dorff
Albert B. Deisseroth
Dickran Kazandjian
Rajeshwari Sridhara
Julia A. Beaver
Ann T. Farrell
R. Angelo de Claro
Richard Pazdur
Show All
Source
Cite
Save
Citations (21)
Emerging oncology drug targets in the 21st century: An FDA analysis.
2020
Journal of Clinical Oncology
Emma C. Scott
Yutao Gong
Ashim Subedee
Dickran Kazandjian
Richard Pazdur
V. Ashutosh Rao
Julia A. Beaver
Julie A. Schneider
Show All
Source
Cite
Save
Citations (0)
1